| Title |
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
|
|---|---|
| Published in |
Drug Design, Development and Therapy, May 2017
|
| DOI | 10.2147/dddt.s130318 |
| Pubmed ID | |
| Authors |
Martin Schiestl, Markus Zabransky, Fritz Sörgel |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 17% |
| Unknown | 5 | 83% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Belgium | 1 | <1% |
| Unknown | 171 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 39 | 23% |
| Student > Bachelor | 24 | 14% |
| Student > Ph. D. Student | 16 | 9% |
| Researcher | 12 | 7% |
| Other | 6 | 3% |
| Other | 17 | 10% |
| Unknown | 58 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 43 | 25% |
| Biochemistry, Genetics and Molecular Biology | 18 | 10% |
| Medicine and Dentistry | 15 | 9% |
| Agricultural and Biological Sciences | 5 | 3% |
| Immunology and Microbiology | 5 | 3% |
| Other | 25 | 15% |
| Unknown | 61 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 531. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2023.
All research outputs
#47,444
of 25,837,817 outputs
Outputs from Drug Design, Development and Therapy
#5
of 2,296 outputs
Outputs of similar age
#973
of 327,148 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 49 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,148 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.